All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @vero_avud on TikTok · 21s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @vero_avud's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Today I over ate on Saxenda and
  2. 0:04Let me tell you I'm hurting my stomach hurts
  3. 0:08it feels like a balloon with too much air and
  4. 0:14All I want to do is just
  5. 0:18Yeah, get it out get it out

Saxenda side effects and tips: what TikTok gets right and wrong

Vero💕

TikTok creator

8.8K viewsWatch on TikTok

Quick answer

Liraglutide (Saxenda) delays gastric emptying through GLP-1 receptor activation, meaning food remains in the stomach significantly longer than it would off-medication. Overeating while on liraglutide predictably produces bloating, abdominal pressure, and nausea because the stomach cannot process the volume at its pharmacologically slowed rate. The symptoms @vero_avud described are consistent with documented GI adverse events in liraglutide trials and represent a direct pharmacological consequence rather than an idiosyncratic drug reaction.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Saxenda side effects and tips: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Saxenda side effects and tips: what TikTok gets right and wrong should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Saxenda side effects and tips: what TikTok gets right and wrong" from Vero💕. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Liraglutide (Saxenda) delays gastric emptying through GLP-1 receptor activation, meaning food remains in the stomach significantly longer than it would off-medication.

The reason this review is not generic is the source wording and the canonical claim label "glp1 why did i do this saxenda saxendatip saxendasuccess saxendaw." In this clip, the useful excerpt is: "Today I over ate on Saxenda and Let me tell you I'm hurting my stomach hurts it feels like a balloon with too much air and All I want to do is just Yeah, get it out get it out" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The SCALE Obesity and Prediabetes trial (Davies et al.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Liraglutide (Saxenda) delays gastric emptying through GLP-1 receptor activation, meaning food remains in the stomach significantly longer than it would off-medication.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Liraglutide (Saxenda) delays gastric emptying through GLP-1 receptor activation, meaning food remains in the stomach significantly longer than it would off-medication. Overeating while on liraglutide predictably produces bloating, abdominal pressure, and nausea because the stomach cannot process the volume at its pharmacologically slowed rate. The symptoms @vero_avud described are consistent with documented GI adverse events in liraglutide trials and represent a direct pharmacological consequence rather than an idiosyncratic drug reaction.
  • Liraglutide delays gastric emptying in a dose-dependent manner, per Halawi et al. (2021, Neurogastroenterology and Motility), making overeating disproportionately uncomfortable compared to being off the medication.
  • The SCALE Obesity and Prediabetes trial (Davies et al., 2015, The Lancet) found GI side effects were the most common adverse events on liraglutide 3.0 mg, with nausea and abdominal discomfort topping the list.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Liraglutide delays gastric emptying in a dose-dependent manner, per Halawi et al. (2021, Neurogastroenterology and Motility), making overeating disproportionately uncomfortable compared to being off the medication.
  • The SCALE Obesity and Prediabetes trial (Davies et al., 2015, The Lancet) found GI side effects were the most common adverse events on liraglutide 3.0 mg, with nausea and abdominal discomfort topping the list.
  • Bloating and abdominal pressure after overeating on Saxenda are not a sign the medication malfunctioned. They are a sign the medication is doing exactly what it is designed to do.
  • Structured dietary counseling alongside GLP-1 prescriptions significantly reduces GI side effects, per Jensterle et al. (2022, International Journal of Molecular Sciences). Ask your prescriber about portion guidance specific to your dose.
  • GLP-1 medications suppress appetite centrally and slow digestion peripherally. Overriding both of those signals at once is a reliable way to feel exactly what @vero_avud described.
  • If GI symptoms from overeating are severe or recurring, that is a clinical conversation worth having with your prescriber about dose titration or dietary adjustments, not a reason to stop the medication without guidance.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @vero_avud actually say?

Short version: she overate while on Saxenda and felt terrible for it. Her exact words were that her stomach "feels like a balloon with too much air" and she just wanted to "get it out." No medical claims, no dosing advice, no miracle promises. Just a person describing real, uncomfortable consequences of eating past the signals her medication was sending her body.

That honesty is actually worth something. Most GLP-1 content on TikTok leans into transformation photos and appetite suppression success stories. This is someone sitting in the discomfort and reporting it plainly. That said, the video gives almost no context about why this happens physiologically, which means viewers walk away with the symptom but not the mechanism.

Does the science back this up?

Yes, and pretty clearly. Liraglutide, the active ingredient in Saxenda, slows gastric emptying significantly. When you eat past your body's cues on a GLP-1 medication, food stays in your stomach longer than it would otherwise. The result is exactly what she described: bloating, pressure, and significant discomfort.

A 2021 study by Halawi et al. published in Neurogastroenterology and Motility confirmed that liraglutide delays gastric emptying in a dose-dependent manner. Separately, the SCALE Obesity and Prediabetes trial (Davies et al., 2015, The Lancet) documented nausea, vomiting, and abdominal discomfort as the most common adverse effects reported by participants on liraglutide 3.0 mg, with incidence highest in the first weeks of treatment and when dietary habits were inconsistent.

The "balloon" sensation she described maps directly to what gastroenterologists call gastroparesis-adjacent delayed emptying. It is not dangerous in most cases, but it is genuinely unpleasant, and it is a predictable consequence of overeating on this drug class.

What did they get wrong (or right)?

She got the subjective experience right. The bloating, the pressure, the urgency to relieve it, all of that is consistent with what the clinical literature describes as GI adverse events on liraglutide. Give her credit for not dramatizing it beyond what it actually is.

What she did not address, and this matters for viewers who might not know better, is that this is not a random or mysterious reaction. It is a pharmacological consequence. Saxenda suppresses appetite through GLP-1 receptor activation in the hypothalamus and slows gastric motility. When you override those satiety signals and eat more than your stomach can process at its now-slower pace, you will feel it.

There is also a missed opportunity here. Some viewers might interpret her experience as the medication "not working" or causing harm unpredictably. It is neither. This is the medication working exactly as designed, and the discomfort is a consequence of eating past its effects, not a side effect of the drug functioning correctly.

What should you actually know?

If you are on Saxenda or any GLP-1 medication, overeating does not just mean consuming extra calories. It means forcing food through a digestive system that is deliberately running slower than usual. The discomfort is not a warning that something went wrong with the drug. It is a warning that the drug's mechanism and your eating behavior are in direct conflict.

Clinically, patients on liraglutide are advised to eat smaller portions, eat slowly, and stop at the first sign of fullness. That is not generic diet advice. It is pharmacology-informed eating guidance. A 2022 review by Jensterle et al. in International Journal of Molecular Sciences noted that GI side effects in GLP-1 users are substantially reduced when patients receive structured dietary counseling alongside their prescription.

  • Do not eat past satiety cues on a GLP-1 medication. The delayed gastric emptying makes overeating disproportionately uncomfortable.
  • If GI symptoms are severe or persistent, contact your prescriber. Dose titration exists for a reason.
  • The bloating and pressure @vero_avud described are among the most commonly reported experiences on liraglutide. You are not alone, and it is not dangerous, but it is preventable.
  • This video is a useful real-world reminder, but it is not a substitute for the dietary guidance your prescriber or pharmacist should be giving you alongside any GLP-1 prescription.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Vero💕 · TikTok creator

8.8K views on this video

Why did I do this? 😩 #saxenda #saxendatip #saxendasuccess #saxendaweightloss #saxendajourney

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about liraglutide delays gastric emptying in a dose-dependent manner, per halawi?

Liraglutide delays gastric emptying in a dose-dependent manner, per Halawi et al. (2021, Neurogastroenterology and Motility), making overeating disproportionately uncomfortable compared to being off the medication.

What does the video say about the scale obesity?

The SCALE Obesity and Prediabetes trial (Davies et al., 2015, The Lancet) found GI side effects were the most common adverse events on liraglutide 3.0 mg, with nausea and abdominal discomfort topping the list.

What does the video say about bloating?

Bloating and abdominal pressure after overeating on Saxenda are not a sign the medication malfunctioned. They are a sign the medication is doing exactly what it is designed to do.

What does the video say about structured dietary counseling alongside glp-1 prescriptions significantly reduces gi side?

Structured dietary counseling alongside GLP-1 prescriptions significantly reduces GI side effects, per Jensterle et al. (2022, International Journal of Molecular Sciences). Ask your prescriber about portion guidance specific to your dose.

What does the video say about glp-1 medications suppress appetite centrally?

GLP-1 medications suppress appetite centrally and slow digestion peripherally. Overriding both of those signals at once is a reliable way to feel exactly what @vero_avud described.

What does the video say about if gi symptoms from overeating?

If GI symptoms from overeating are severe or recurring, that is a clinical conversation worth having with your prescriber about dose titration or dietary adjustments, not a reason to stop the medication without guidance.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Vero💕, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.